Ocular Bioavailability

Ocular Bioavailability is the fraction of an administered ophthalmic drug that reaches the systemic circulation or target ocular tissues in an active form, distinguishing it from other pharmacokinetic parameters by specifically quantifying the extent of drug absorption and availability within ocular structures following ocular administration.

1.1K

Publications

45.9K

Citations

4K

Authors

1K

Institutions

Publications per year

2017–2026

305

Authors

4K

  1. AU
    Arto Urtti

    University of Eastern Finland, Finland

    32 publications · 1.5K citations

    25

    h-index

  2. AK
    Ashim K. Mitra

    University of Missouri–Kansas City, United States

    15 publications · 662 citations

    14

    h-index

  3. VH
    Vincent H.L. Lee

    University of Southern California, United States

    13 publications · 672 citations

    13

    h-index

  4. JR
    Joseph R. Robinson

    University of Wisconsin–Madison, United States

    13 publications · 1.1K citations

    13

    h-index

  5. ET
    Elisa Toropainen

    University of Eastern Finland, Finland

    12 publications · 552 citations

    12

    h-index

1–5 of 4K

Venues

  1. Journal of Ocular Pharmacology and Therapeutics

    OPT · 122 publications · 3.5K citations

    34

    h-index

  2. International Journal of Pharmaceutics

    63 publications · 3K citations

    33

    h-index

  3. PubMed

    Repository · 74 publications · 2.9K citations

    31

    h-index

  4. Investigative Ophthalmology & Visual Science

    IOVS · 37 publications · 2.8K citations

    27

    h-index

  5. Journal of Pharmaceutical Sciences

    39 publications · 2.1K citations

    26

    h-index

1–5